Comparing 3D, 2.5 D, and 2D approaches to brain image auto-segmentation
A Avesta, S Hossain, MD Lin, M Aboian, HM Krumholz… - Bioengineering, 2023 - mdpi.com
Deep-learning methods for auto-segmenting brain images either segment one slice of the
image (2D), five consecutive slices of the image (2.5D), or an entire volume of the image (3D). …
image (2D), five consecutive slices of the image (2.5D), or an entire volume of the image (3D). …
Effect of transcranial low-level light therapy vs sham therapy among patients with moderate traumatic brain injury: a randomized clinical trial
Importance Preclinical studies have shown that transcranial near-infrared low-level light therapy
(LLLT) administered after traumatic brain injury (TBI) confers a neuroprotective response…
(LLLT) administered after traumatic brain injury (TBI) confers a neuroprotective response…
Comparing Detection Schemes for Adversarial Images against Deep Learning Models for Cancer Imaging
MZ Joel, A Avesta, DX Yang, JG Zhou, A Omuro… - Cancers, 2023 - mdpi.com
Simple Summary While deep learning has become a powerful tool in analysis of cancer
imaging, deep learning models have potential vulnerabilities that pose security threats in the …
imaging, deep learning models have potential vulnerabilities that pose security threats in the …
3D Capsule Networks for Brain MRI Segmentation
… Arman Avesta Arman Avesta is on the trainee editorial board of Radiology: Artificial
Intelligence. Journal policy recused the author from having any role in the peer review of this …
Intelligence. Journal policy recused the author from having any role in the peer review of this …
[HTML][HTML] The brain tumor segmentation (brats-mets) challenge 2023: Brain metastasis segmentation on pre-treatment mri
Clinical monitoring of metastatic disease to the brain can be a laborious and timeconsuming
process, especially in cases involving multiple metastases when the assessment is …
process, especially in cases involving multiple metastases when the assessment is …
PACS-Integrated Tools for Peritumoral Edema Volumetrics Provide Additional Information to RANO-BM-Based Assessment of Lung Cancer Brain Metastases after …
…, S Varghese, I Dixe de Oliveira Santo, A Avesta… - Cancers, 2023 - mdpi.com
Simple Summary Peritumoral edema can contribute significantly to the development of
neurological symptoms in patients with brain metastases (METS), but the quantification of edema …
neurological symptoms in patients with brain metastases (METS), but the quantification of edema …
Clinical Informatics Approaches to Facilitate Cancer Data Sharing
S Aneja, A Avesta, H Xu… - Yearbook of Medical …, 2023 - thieme-connect.com
Objectives: Despite growing enthusiasm surrounding the utility of clinical informatics to improve
cancer outcomes, data availability remains a persistent bottleneck to progress. Difficulty …
cancer outcomes, data availability remains a persistent bottleneck to progress. Difficulty …
Comparing 3D, 2.5 D, and 2D Approaches to Brain Image Segmentation
A Avesta, S Hossain, MD Lin, M Aboian, HM Krumholz… - medRxiv, 2022 - medrxiv.org
Deep-learning methods for auto-segmenting brain images either segment one slice of the
image (2D), five consecutive slices of the image (2.5D), or an entire volume of the image (3D). …
image (2D), five consecutive slices of the image (2.5D), or an entire volume of the image (3D). …
Application of novel PACS-based informatics platform to identify imaging based predictors of CDKN2A allelic status in glioblastomas
…, L Jekel, S Merkaj, D Ramakrishnan, A Avesta… - Scientific Reports, 2023 - nature.com
Gliomas with CDKN2A mutations are known to have worse prognosis but imaging features
of these gliomas are unknown. Our goal is to identify CDKN2A specific qualitative imaging …
of these gliomas are unknown. Our goal is to identify CDKN2A specific qualitative imaging …
Systematic Literature Review of Machine Learning Algorithms Using Pretherapy Radiologic Imaging for Glioma Molecular Subtype Prediction
…, BV Marquez-Nostra, A Avesta… - American Journal …, 2023 - Am Soc Neuroradiology
BACKGROUND: The molecular profile of gliomas is a prognostic indicator for survival,
driving clinical decision-making for treatment. Pathology-based molecular diagnosis is …
driving clinical decision-making for treatment. Pathology-based molecular diagnosis is …